LabTurbo Biotech Corporation (7725) Stock Statistics & Valuation Metrics
Total Valuation
LabTurbo Biotech Corporation has a market cap or net worth of TWD 1.01B. The enterprise value is ―.
- Market Cap
- TWD 1.01B
- Enterprise Value
- ―
Share Statistics
LabTurbo Biotech Corporation has 48,326,633 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 48,326,633
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
LabTurbo Biotech Corporation’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -15.11%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -15.11%
- Return on Capital Employed (ROCE)
- -0.16
- Revenue Per Employee
- 2.64M
- Profits Per Employee
- -4.38M
- Employee Count
- 30
- Asset Turnover
- 0.06
- Inventory Turnover
- 1.41
Valuation Ratios
The current PE Ratio of LabTurbo Biotech Corporation is -25.61. LabTurbo Biotech Corporation’s PEG ratio is -0.26.
- PE Ratio
- -25.61
- PS Ratio
- 10.68
- PB Ratio
- 0.90
- Price to FCF
- -10.79
- Price to Operating Cash Flow
- -11.38
- PEG Ratio
- -0.26
Income Statement
In the last 12 months, LabTurbo Biotech Corporation had revenue of 79.07M and earned -131.54M in profits. Earnings per share was -2.74.
- Revenue
- 79.07M
- Gross Profit
- -14.03M
- Operating Income
- -188.54M
- Pretax Income
- -137.43M
- Net Income
- -131.54M
- EBITDA
- -143.41M
- Earnings Per Share (EPS)
- -2.74
Cash Flow
In the last 12 months, operating cash flow was -91.73M and capital expenditures -1.58M, giving a free cash flow of -93.31M billion.
- Operating Cash Flow
- -91.73M
- Free Cash Flow
- -93.31M
- Free Cash Flow per Share
- -1.88
Dividends & Yields
LabTurbo Biotech Corporation pays an annual dividend of ―, resulting in a dividend yield of 0.96%
- Dividend Per Share
- ―
- Dividend Yield
- 0.96%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.27%
- Earnings Yield
- -3.75%
Stock Price Statistics
- Beta
- 0.21
- 52-Week Price Change
- -18.43%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 12.33
- Average Volume (3m)
- 13.65K
Financial Position
LabTurbo Biotech Corporation as a current ratio of 18.21, with Debt / Equity ratio of 1.80%
- Current Ratio
- 18.21
- Quick Ratio
- 16.86
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 2.12
- Interest Coverage Ratio
- -401.14
Taxes
In the past 12 months, LabTurbo Biotech Corporation has paid -5.90M in taxes.
- Income Tax
- -5.90M
- Effective Tax Rate
- 0.04
Enterprise Valuation
LabTurbo Biotech Corporation EV to EBITDA ratio is -5.70, with an EV/FCF ratio of -9.07.
- EV to Sales
- 8.97
- EV to EBITDA
- -5.70
- EV to Free Cash Flow
- -9.07
- EV to Operating Cash Flow
- -9.23
Balance Sheet
LabTurbo Biotech Corporation has TWD 816.13M in cash and marketable securities with TWD 17.37M in debt, giving a net cash position of TWD 798.76M billion.
- Cash & Marketable Securities
- TWD 816.13M
- Total Debt
- TWD 17.37M
- Net Cash
- TWD 798.76M
- Net Cash Per Share
- TWD 16.53
- Tangible Book Value Per Share
- TWD 22.68
Margins
Gross margin is -13.74%, with operating margin of -202.69%, and net profit margin of -41.54%.
- Gross Margin
- -13.74%
- Operating Margin
- -202.69%
- Pretax Margin
- -42.51%
- Net Profit Margin
- -41.54%
- EBITDA Margin
- -157.46%
- EBIT Margin
- -202.69%
Analyst Forecast
The average price target for LabTurbo Biotech Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 37.11%
- EPS Growth Forecast
- 75.25%
